Quantitative V-gene-targeted T cell Receptor Sequencing as a Biomarker in Type 1 Diabetes
NKX6.1: Actionable Biomarker linked to Islet Function & Islet Transplantation Clinical Outcomes
Saliva-based at-home GRS Testing for Scalable & Accessible T1D Screening - Yuta Matsuda, T1D Scout
Type 1 Diabetes Monitoring Panel - Challenges for Implementation and Engagement
Type 1 Diabetes Screening Panel: Moving from Research to Clinical Implementation
Panel: What would the earliest detection of Type 1 Diabetes look like?
T1D Th1nk Tank: Nathan Steenbuck, PhD Candidate, University of Zürich Bodenmiller Laboratory
T1D Think Tank: Robert Moulder, PhD, Turku Bioscience
Indiana University School of Medicine Site Visit
T1D Th1nk Tank: Anand Hardikar, PhD, Western Sydney University
Ask the Expert: Emmanuel Bosi, MD, San Raffaele Hospital
the(sugar)science presents: Debate - Autoantibodies in T1D: Biomarkers or Mediators of Destruction?
Site Visit Vanderbilt SOM: Fireside Chat: T1D prediction and prevention
Ask the Expert: Alessandra Petrelli, MD PhD, University of Milan
Ask The Expert: Abhijeet Patil, PhD, University of Pennsylvania
Ask the Expert: Maria Ruiz, PhD, Mt. Sinai Hospital, NYC
Ask the Expert: Inna Starskaia, Msc, PhD Candidate, Turku Bioscience Centre
Ask the Expert: Nick Thomas, MD PhD, University of Exeter
Ask the Expert: Ulf Hannelius, PhD MBA CEO, Diamyd Medical
A Surviving Beta Cell Subpopulation Enriched in Patients with Type 1 Diabetes - Max Spurrell
The Sugar Science June 25, 2026 8:25 am